Supported contents

The adoption of telemedicine and its range of applications grew exponentially in the early days of the Covid-19 pandemic, and the general consensus now is that it is here to stay, albeit perhaps with a more hybrid bias of in-person…

Introduction Among the most crucial problems caused by Covid-19 pandemics are the difficultyin the management of chronic diseases, the comorbidities, the impact on life expectancy, the search for therapy and prevention, the host interactions with the vaccines. Cancer patients constitute…

Although telemedicine was to various degrees already in existence, with the Covid-19 pandemic it suddenly became a must, prompted by lockdown regulations and fear of contagion. Solutions had to be found and implemented quickly, and changes in the delivery of…

Interstitial lung disease (ILD) is a collective term used to describe a heterogeneous group of over 200 different non-infectious diseases affecting the lung parenchyma, that are characterised by nonspecific clinical, radiological, and pathological patterns. Identifiable causes of ILD include infections…

Introduction Over the last years, interest in precision testing in oncology has increased dramatically. Precision testing allows the tailoring of medical treatment or drug administration to the individual molecular characteristics of a given patient’s tumour. As such, it is part…

The third webinar in the Telemedicine in Cancer Care Project was chaired by Gustavo Werutsky, Clinical Director of the Breast Cancer Centre at Hospital São Lucas PUCRS, Porto Alegre, Brazil, and Chair of the Latin American Corporative Oncology Group. The…

The session was chaired by Marlene Thomas, Global Medical Lead for Integrated Health Care Solutions at Roche Headquarters. In February 2021, Europe's Beating Cancer Plan was launched. The plan takes a very holistic approach to the patient journey as it…

Antonella Cardone, Director of the European Cancer Patient Coalition and Board Member of All.Can Brussels, opened the session with a brief recap on All.Can and its initiatives. All.Can is an international multi-stakeholder platform, a thought-leader in cancer care in Europe…

Chair and first speaker of this webinar was Florian Scotté, medical oncologist and Head of the Patient Pathway division at the Institute Gustave Roussy, Villejuif, France. Telemedicine and technological innovation in cancer care The first tool of the remote hospital,…

The SPCC Webinar entitled “Examples of efficiency in cancer care from the All.Can efficiency Hub – Part 1” was held on October 25, 2021. All.Can’s efficiency hub aims to collect as many examples as possible on how to improve efficiency…